• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Castration induces Parkinson disease pathologies in young male mice via inducible nitric-oxide synthase.去势通过诱导型一氧化氮合酶诱导年轻雄性小鼠发生帕金森病病变。
J Biol Chem. 2013 Jul 19;288(29):20843-20855. doi: 10.1074/jbc.M112.443556. Epub 2013 Jun 6.
2
Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.金雀异黄素通过 Nrf2/HO-1 通路减轻 MPTP 诱导的黑质纹状体多巴胺能神经元丢失和 α-突触核蛋白的积累。
Mol Neurobiol. 2019 Jan;56(1):39-55. doi: 10.1007/s12035-018-1020-1. Epub 2018 Apr 19.
3
Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.吉非贝齐通过 PPARα 依赖的星形胶质细胞 GDNF 通路保护帕金森病小鼠模型中的多巴胺能神经元。
J Neurosci. 2021 Mar 10;41(10):2287-2300. doi: 10.1523/JNEUROSCI.3018-19.2021. Epub 2021 Jan 29.
4
Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.一氧化氮释放与抗炎活性相结合可保护黑质纹状体多巴胺能神经支配并预防帕金森病 1-甲基-4-苯基-1,2,3,6-四氢吡啶模型中的运动障碍。
J Neuroinflammation. 2010 Nov 23;7:83. doi: 10.1186/1742-2094-7-83.
5
Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease.肉桂治疗可上调神经保护蛋白帕金蛋白和DJ-1,并在帕金森病小鼠模型中保护多巴胺能神经元。
J Neuroimmune Pharmacol. 2014 Sep;9(4):569-81. doi: 10.1007/s11481-014-9552-2. Epub 2014 Jun 20.
6
Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.纹状体内脂多糖帕金森病模型在 C57BL/6 小鼠中的进一步特征描述。
Int J Mol Sci. 2021 Jul 9;22(14):7380. doi: 10.3390/ijms22147380.
7
Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.ω-3 多不饱和脂肪酸在帕金森病 6-OHDA 模型中的神经保护作用是通过降低诱导型一氧化氮合酶实现的。
Nutr Neurosci. 2018 Jun;21(5):341-351. doi: 10.1080/1028415X.2017.1290928. Epub 2017 Feb 21.
8
Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.在帕金森病的临床前模型中,一种具有口服活性的夹竹桃麻素衍生物的抗炎和神经保护作用。
J Neuroinflammation. 2012 Oct 23;9:241. doi: 10.1186/1742-2094-9-241.
9
The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.黑质注射脂多糖对多巴胺能功能障碍和胶质细胞活化的急性及长期影响。
Eur J Neurosci. 2005 Jul;22(2):317-30. doi: 10.1111/j.1460-9568.2005.04220.x.
10
Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.替米沙坦通过调节 C57BL/6J 小鼠中α-突触核蛋白和神经营养因子(BDNF 和 GDNF)的表达来减轻 MPTP 诱导的多巴胺能变性和运动功能障碍。
Neuropharmacology. 2013 Oct;73:98-110. doi: 10.1016/j.neuropharm.2013.05.025. Epub 2013 Jun 6.

引用本文的文献

1
Sex and gender differences in the molecular etiology of Parkinson's disease: considerations for study design and data analysis.帕金森病分子病因学中的性别差异:研究设计与数据分析的考量
Biol Sex Differ. 2025 Feb 3;16(1):7. doi: 10.1186/s13293-025-00692-w.
2
17β-Trenbolone Exposure Enhances Muscle Activity and Exacerbates Parkinson's Disease Progression in Male Mice.17β-群勃龙暴露增强雄性小鼠的肌肉活动并加剧帕金森病进展
Mol Neurobiol. 2025 Mar;62(3):3053-3066. doi: 10.1007/s12035-024-04455-3. Epub 2024 Sep 2.
3
[Androgens and Parkinson's disease: the role in humans and in experiment].[雄激素与帕金森病:在人类及实验中的作用]
Probl Endokrinol (Mosk). 2022 Sep 4;68(6):146-156. doi: 10.14341/probl13148.
4
Evidences for Mutant Huntingtin Inducing Musculoskeletal and Brain Growth Impairments via Disturbing Testosterone Biosynthesis in Male Huntington Disease Animals.证据表明,突变亨廷顿蛋白通过干扰雄性亨廷顿病动物的睾丸酮生物合成,导致骨骼肌肉和大脑生长受损。
Cells. 2022 Nov 25;11(23):3779. doi: 10.3390/cells11233779.
5
Androgens and Parkinson's Disease: A Review of Human Studies and Animal Models.雄激素与帕金森病:人体研究及动物模型综述
Androg Clin Res Ther. 2021 Dec 23;2(1):294-303. doi: 10.1089/andro.2021.0011. eCollection 2021.
6
Nervonic acid amends motor disorder in a mouse model of Parkinson's disease.神经酸改善帕金森病小鼠模型的运动障碍。
Transl Neurosci. 2021 May 25;12(1):237-246. doi: 10.1515/tnsci-2020-0171. eCollection 2021 Jan 1.
7
Androgen Therapy in Neurodegenerative Diseases.神经退行性疾病中的雄激素治疗
J Endocr Soc. 2020 Aug 21;4(11):bvaa120. doi: 10.1210/jendso/bvaa120. eCollection 2020 Nov 1.
8
Sex and the dopaminergic system: Insights from addiction studies.性别与多巴胺能系统:成瘾研究的见解
Handb Clin Neurol. 2020;175:141-165. doi: 10.1016/B978-0-444-64123-6.00011-4.
9
Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson's disease.依帕司他通过减轻利血平诱导的帕金森病小鼠模型中的氧化应激和炎症来改善运动症状。
Animal Model Exp Med. 2019 Dec 30;3(1):9-21. doi: 10.1002/ame2.12097. eCollection 2020 Mar.
10
GRK2 enforces androgen receptor dependence in the prostate and prostate tumors.GRK2 增强前列腺和前列腺肿瘤中雄激素受体的依赖性。
Oncogene. 2020 Mar;39(11):2424-2436. doi: 10.1038/s41388-020-1159-x. Epub 2020 Jan 20.

本文引用的文献

1
Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor α: implications for late infantile Batten disease therapy.吉非贝齐和非诺贝特,经美国食品和药物管理局批准的降脂药物,通过过氧化物酶体增殖物激活受体 α 上调脑细胞中的三肽基肽酶 1:对晚期婴儿神经鞘脂沉积病治疗的启示。
J Biol Chem. 2012 Nov 9;287(46):38922-35. doi: 10.1074/jbc.M112.365148. Epub 2012 Sep 18.
2
Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease.苯丁酸钠可控制神经炎症和抗氧化活性,保护帕金森病小鼠模型中的多巴胺能神经元。
PLoS One. 2012;7(6):e38113. doi: 10.1371/journal.pone.0038113. Epub 2012 Jun 18.
3
Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders.吉非贝齐,一种降脂药物,可诱导神经胶质细胞中的细胞因子信号转导抑制因子 3:对神经退行性疾病的影响。
J Biol Chem. 2012 Aug 3;287(32):27189-203. doi: 10.1074/jbc.M112.346932. Epub 2012 Jun 8.
4
Testing NF-κB-based therapy in hemiparkinsonian monkeys.在偏侧帕金森病猴中进行 NF-κB 为基础的治疗的测试。
J Neuroimmune Pharmacol. 2012 Sep;7(3):544-56. doi: 10.1007/s11481-012-9377-9. Epub 2012 Jun 3.
5
Is GDNF beneficial in Parkinson disease?胶质细胞源性神经营养因子(GDNF)对帕金森病有益吗?
Nat Rev Neurol. 2011 Sep 20;7(11):600-2. doi: 10.1038/nrneurol.2011.149.
6
Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons.苯甲酸钠是肉桂的一种代谢物,也是一种食品添加剂,可上调星形胶质细胞和神经元中的神经保护帕金森病蛋白 DJ-1。
J Neuroimmune Pharmacol. 2012 Jun;7(2):424-35. doi: 10.1007/s11481-011-9286-3. Epub 2011 Jun 24.
7
Prospects of statins in Parkinson disease.他汀类药物在帕金森病中的应用前景。
Neuroscientist. 2011 Jun;17(3):244-55. doi: 10.1177/1073858410385006. Epub 2011 Jan 20.
8
Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease.辛伐他汀可抑制p21ras的激活,并在帕金森病小鼠模型中预防多巴胺能神经元的丢失。
J Neurosci. 2009 Oct 28;29(43):13543-56. doi: 10.1523/JNEUROSCI.4144-09.2009.
9
Effects of orchidectomy on nigro-striatal dopaminergic function: behavioral and physiological evidence.去势对黑质纹状体多巴胺能功能的影响:行为和生理证据。
J Neuroendocrinol. 1989 Aug 1;1(4):285-90. doi: 10.1111/j.1365-2826.1989.tb00117.x.
10
The relation of testosterone levels with fatigue and apathy in Parkinson's disease.帕金森病中睾酮水平与疲劳和冷漠的关系。
Clin Neurol Neurosurg. 2009 Jun;111(5):412-4. doi: 10.1016/j.clineuro.2008.11.019. Epub 2009 Jan 8.

去势通过诱导型一氧化氮合酶诱导年轻雄性小鼠发生帕金森病病变。

Castration induces Parkinson disease pathologies in young male mice via inducible nitric-oxide synthase.

机构信息

From the Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612.

From the Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612.

出版信息

J Biol Chem. 2013 Jul 19;288(29):20843-20855. doi: 10.1074/jbc.M112.443556. Epub 2013 Jun 6.

DOI:10.1074/jbc.M112.443556
PMID:23744073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3774356/
Abstract

Although Parkinson disease (PD) is a progressive neurodegenerative disorder, available animal models do not exhibit irreversible neurodegeneration, and this is a major obstacle in finding out an effective drug against this disease. Here we delineate a new irreversible model to study PD pathogenesis. The model is based on simple castration of young male mice. Levels of inducible nitric-oxide synthase (iNOS), glial markers (glial fibrillary acidic protein and CD11b), and α-synuclein were higher in nigra of castrated male mice than normal male mice. On the other hand, after castration, the level of glial-derived neurotrophic factor (GDNF) markedly decreased in the nigra of male mice. Accordingly, castration also induced the loss of tyrosine hydroxylase-positive neurons in the nigra and decrease in tyrosine hydroxylase-positive fibers and neurotransmitters in the striatum. Reversal of nigrostriatal pathologies in castrated male mice by subcutaneous implantation of 5α-dihydrotestosterone pellets validates an important role of male sex hormone in castration-induced nigrostriatal pathology. Interestingly, castration was unable to cause glial activation, decrease nigral GDNF, augment the death of nigral dopaminergic neurons, induce the loss of striatal fibers, and impair neurotransmitters in iNOS(-/-) male mice. Furthermore, we demonstrate that iNOS-derived NO is responsible for decreased expression of GDNF in activated astrocytes. Together, our results suggest that castration induces nigrostriatal pathologies via iNOS-mediated decrease in GDNF. These results are important because castrated young male mice may be used as a simple, toxin-free, and nontransgenic animal model to study PD-related nigrostriatal pathologies, paving the way for easy drug screening against PD.

摘要

虽然帕金森病(PD)是一种进行性神经退行性疾病,但现有的动物模型并不表现出不可逆转的神经退行性变,这是寻找有效治疗这种疾病的药物的主要障碍。在这里,我们描述了一种新的不可逆模型来研究 PD 的发病机制。该模型基于对年轻雄性小鼠进行简单的去势。去势雄性小鼠的黑质中诱导型一氧化氮合酶(iNOS)、神经胶质标志物(胶质纤维酸性蛋白和 CD11b)和α-突触核蛋白的水平高于正常雄性小鼠。另一方面,去势后,雄性小鼠黑质中的胶质源性神经营养因子(GDNF)水平明显下降。因此,去势也诱导了黑质中酪氨酸羟化酶阳性神经元的丧失以及纹状体中酪氨酸羟化酶阳性纤维和神经递质的减少。通过皮下植入 5α-二氢睾酮丸来逆转去势雄性小鼠的黑质纹状体病理学,验证了雄性性激素在去势诱导的黑质纹状体病理学中的重要作用。有趣的是,去势不能引起神经胶质细胞的激活,减少黑质 GDNF,增加黑质多巴胺能神经元的死亡,诱导纹状体纤维的丧失,并损害 iNOS(-/-)雄性小鼠纹状体中的神经递质。此外,我们证明 iNOS 衍生的 NO 负责激活的星形胶质细胞中 GDNF 表达的降低。总之,我们的结果表明,去势通过 iNOS 介导的 GDNF 减少诱导黑质纹状体病理学。这些结果很重要,因为去势的年轻雄性小鼠可能被用作一种简单、无毒素和非转基因的动物模型来研究与 PD 相关的黑质纹状体病理学,为针对 PD 的药物筛选铺平了道路。